# In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies

> **NCT04873427** · — · TERMINATED · sponsor: **Clinica Luganese Moncucco** · enrollment: 40 (actual)

## Conditions studied

- Prostate Cancer
- Genetic Predisposition

## Interventions

- **GENETIC:** clonal heterogeneity evaluation

## Key facts

- **NCT ID:** NCT04873427
- **Lead sponsor:** Clinica Luganese Moncucco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-15
- **Primary completion:** 2023-01-15
- **Final completion:** 2023-01-15
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** The results of the genomic analyses were compromised due to the low DNA concentration.
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04873427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04873427, "In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04873427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*